A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback